Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

PURPOSE: On initial publication of GI Intergroup Radiation Therapy Oncology Group (RTOG) 98-11 [A Phase III Randomized Study of 5-Fluorouracil (5-FU), Mitomycin, and Radiotherapy Versus 5-Fluorouracil, Cisplatin and Radiotherapy in Carcinoma of the Anal Canal], concurrent chemoradiation (CCR) with f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gunderson, Leonard L., Winter, Kathryn A., Ajani, Jaffer A., Pedersen, John E., Moughan, Jennifer, Benson, Al B., Thomas, Charles R., Mayer, Robert J., Haddock, Michael G., Rich, Tyvin A., Willett, Christopher G.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2012
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3515768/
https://ncbi.nlm.nih.gov/pubmed/23150707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.43.8085
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares